Samuel C. Dudley, Jr., Chicago US
Samuel C. Dudley, Jr., Chicago, IL US
Patent application number | Description | Published |
---|---|---|
20090092998 | MARKER FOR ARRHYTHMIA RISK - The present invention relates to markers and methods for determining risk of ventricular arrhythmia in an individual. By using the markers of the present invention, individual with high risk of ventricular arrhythmia can properly be detected and treated. The present inventors have discovered that IL-6 and/or DROMs have strongly positive correlation with the risk of ventricular arrhythmia. | 04-09-2009 |
20090105181 | Modulation of sodium channels by nicotinamide adenine dinucleotide - The present invention relates to the use of oxidized nicotinamide adenine dinucleotide (NAD | 04-23-2009 |
20100233727 | MARKER FOR ARRHYTHMIA RISK - The present invention relates to markers and methods for determining risk of ventricular arrhythmia in an African American or woman patient. By using the markers of the present invention, individual with high risk of ventricular arrhythmia can properly be detected and treated. The present inventors have discovered that, in African American and women, IL-6 and/or DROMs and/or CRP have strongly positive correlation with the risk of ventricular arrhythmia. | 09-16-2010 |
20110144192 | Method for modulating or controlling sodium channel current by reactive oxygen species (ROS) originating from mitochondria - Method for modulating or controlling sodium channel current of a cell includes inducing mitochondrial reactive oxygen species (ROS) production in the cell. | 06-16-2011 |
20110288044 | Modulation of sodium channels by nicotinamide adenine dinucleotide - The present invention relates to the use of oxidized nicotinamide adenine dinucleotide (NAD | 11-24-2011 |
20120288486 | Method for Ameliorating or Preventing Arrhythmic Risk Associated with Cardiomyopathy - A method for reducing arrhythmic risk associated with cardiomyopathy includes administering a composition containing NAD | 11-15-2012 |
20120289482 | Method for modulating or controlling connexin 43(Cx43) level of a cell and reducing arrhythmic risk - A method of modulating or controlling connexin 43 (Cx43) level of a cell includes inducing mitochondrial reactive oxygen species (ROS) production in the cell. | 11-15-2012 |
20120308542 | Method for Ameliorating or Preventing Arrhythmic Risk Associated with Cardiomyopathy by Improving Conduction Velocity - A method for reducing arrhythmic risk associated with cardiomyopathy by improving conduction velocity, includes administering a composition containing NAD | 12-06-2012 |
20130065903 | Method of Improving Diastolic Dysfunction - A method of treating, preventing, reversing, or ameliorating diastolic dysfunction includes reducing S-glutathionylated myosin binding protein-C (MyBP-C) level by administering to a host in need thereof a therapeutically effective amount of tetrahydrobiopterin (BH | 03-14-2013 |